このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Cellectar Biosciences マネジメント
マネジメント 基準チェック /24
現在、CEO に関する十分な情報がありません。
主要情報
Jim Caruso
最高経営責任者
US$2.0m
報酬総額
| CEO給与比率 | 30.5% |
| CEO在任期間 | 9yrs |
| CEOの所有権 | 0.1% |
| 経営陣の平均在職期間 | 2.3yrs |
| 取締役会の平均在任期間 | 8.1yrs |
経営陣の近況
Recent updates
Cellectar Biosciences: A Shoestring Opportunity You're About To Miss
Feb 12Here's Why We're Watching Cellectar Biosciences' (NASDAQ:CLRB) Cash Burn Situation
Aug 23
Cellectar Biosciences GAAP EPS of -$1.22 misses by $0.19
Aug 05Cellectar announces reverse stock split
Jul 21We're Keeping An Eye On Cellectar Biosciences' (NASDAQ:CLRB) Cash Burn Rate
May 10Is Cellectar Biosciences (NASDAQ:CLRB) In A Good Position To Invest In Growth?
Jan 20Is Cellectar Biosciences (NASDAQ:CLRB) In A Good Position To Deliver On Growth Plans?
Oct 05Cellectar shares fall after mid-stage CLR 131 trial data fails to impress
Jun 04We're Hopeful That Cellectar Biosciences (NASDAQ:CLRB) Will Use Its Cash Wisely
May 20Cellectar Biosciences EPS beats by $0.03
May 10Cellectar gets notification of formal grant from Australian and Mexican patent authorities
Apr 27Cellectar commences pivotal trial of CLR 131 in a rare form bone marrow cancer
Jan 12Cellectar Bio readies stock offering
Dec 23We're Keeping An Eye On Cellectar Biosciences' (NASDAQ:CLRB) Cash Burn Rate
Nov 30
Cellectar Biosciences EPS beats by $0.05
Nov 09Cellectar Bio's lead asset shows encouraging action in early-stage study of pediatric tumors
Nov 05CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$51m |
| Dec 31 2023 | US$2m | US$600k | -US$38m |
| Sep 30 2023 | n/a | n/a | -US$38m |
| Jun 30 2023 | n/a | n/a | -US$32m |
| Mar 31 2023 | n/a | n/a | -US$31m |
| Dec 31 2022 | US$1m | US$569k | -US$29m |
| Sep 30 2022 | n/a | n/a | -US$27m |
| Jun 30 2022 | n/a | n/a | -US$25m |
| Mar 31 2022 | n/a | n/a | -US$24m |
| Dec 31 2021 | US$2m | US$523k | -US$24m |
| Sep 30 2021 | n/a | n/a | -US$22m |
| Jun 30 2021 | n/a | n/a | -US$20m |
| Mar 31 2021 | n/a | n/a | -US$17m |
| Dec 31 2020 | US$1m | US$475k | -US$15m |
| Sep 30 2020 | n/a | n/a | -US$15m |
| Jun 30 2020 | n/a | n/a | -US$15m |
| Mar 31 2020 | n/a | n/a | -US$14m |
| Dec 31 2019 | US$934k | US$451k | -US$14m |
| Sep 30 2019 | n/a | n/a | -US$15m |
| Jun 30 2019 | n/a | n/a | -US$16m |
| Mar 31 2019 | n/a | n/a | -US$16m |
| Dec 31 2018 | US$770k | US$425k | -US$15m |
| Sep 30 2018 | n/a | n/a | -US$17m |
| Jun 30 2018 | n/a | n/a | -US$15m |
| Mar 31 2018 | n/a | n/a | -US$16m |
| Dec 31 2017 | US$994k | US$410k | -US$15m |
報酬と市場: Jimの 総報酬 ($USD 1.97M ) は、 US市場 ($USD 667.63K ) の同規模の企業の平均を上回っています。
報酬と収益: Jimの報酬は増加しましたが、会社は利益を上げていません。
CEO（最高経営責任者
Jim Caruso (65 yo)
9yrs
在職期間
US$1,965,140
報酬
Mr. James V. Caruso, also known as Jim, has been the Chief Executive Officer and President of Cellectar Biosciences, Inc. since June 15, 2015. Mr. Caruso served as the Chief Commercial Officer and Executiv...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 9yrs | US$1.97m | 0.14% $ 165.4k | |
| VP, CFO & Secretary | 2.3yrs | US$1.11m | 0.12% $ 143.1k | |
| Chief Operating Officer | 2.3yrs | US$1.36m | 0.15% $ 178.6k | |
| Chief Commercial Officer | 1.6yrs | データなし | 0.11% $ 133.1k | |
| Senior Vice President of Medical | 1.3yrs | データなし | 0.15% $ 184.9k |
2.3yrs
平均在職期間
52yo
平均年齢
経験豊富な経営陣: CLRBの経営陣は 経験豊富 であると考えられます ( 2.3年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 9yrs | US$1.97m | 0.14% $ 165.4k | |
| Independent Director | 16.3yrs | US$93.25k | 0.017% $ 21.0k | |
| Independent Director | 7.2yrs | US$93.25k | 0.0054% $ 6.5k | |
| Independent Director | 9yrs | US$93.25k | 0% $ 0 | |
| Independent Chairman of the Board | 7.2yrs | US$109.88k | 0.0070% $ 8.4k | |
| Independent Director | 3yrs | US$48.25k | 0% $ 0 |
8.1yrs
平均在職期間
62.5yo
平均年齢
経験豊富なボード: CLRBの 取締役会 は 経験豊富 であると考えられます ( 8.1年の平均在任期間)。